Nevro wins FDA nod for AI-driven spinal cord stimulation tech
Nevro (NYSE:NVRO) announced today that it received FDA approval for an AI-powered, personalized pain management platform for spinal cord stimulation.
Nevro (NYSE:NVRO) announced today that it received FDA approval for an AI-powered, personalized pain management platform for spinal cord stimulation.
Neurable announced today that it launched the MW75 Neuro smart headphones integrated with its brain-computer interface (BCI) technology.
The new device offers unified visualisation with true 4K Imaging and 4K narrow band imaging as well as blue light observation.